Hope for Cancer Patients

Greek Researcher Developed Vaccine
A Greek researcher developed a vaccine, which stimulates the immune system and hence gives hopes for life extension to cancer patients. As vaccine developer and director of the Medical Research Institute in Paris Kostas Kosmatopoulos said, the vaccine was tested on 59 patients suffering from terminal cancer and 75% of them lived for an entire year, when life expectancy ranged from 6 to 9 months. At the same time, all patients' immune system was stimulated and there were no side effects. These facts encourage the researchers. Although the vaccine does not promise cancer cure, 30% of patients (20 of the 59) showed stabilisation of the disease. In particular, Oncology professor at the University of Crete Vassilis Georgoulias reported the case of a patient with breast cancer, who was stabilised for two years! The next step is comparative testing, to evaluate results.
The next step is comparative research on patients who have taken the vaccine and on others who have not. Researchers will focus their study on inhibiting the disease from developing and for this reason the vaccine will be tested on patients who have had a primary tumour removed, but are still in a high-risk category. The comparative research results for patients in Greece, Italy, France, Germany and perhaps the Netherlands will be released in three or four years and give the green light for the vaccine's circulation in the market